Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
Condition(s):Triple Negative Breast Cancer; Triple Negative Breast Neoplasms; TNBC – Triple-Negative Breast Cancer; Triple-negative Breast CarcinomaLast Updated:December 14, 2023Terminated